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Targeting a killer
Noninvasive therapy
halts arrhythmia

outlook.wustl.edu

Outlook 3

SARA MOSER

MATT MILLER

FEATURES

7

Big data
Putting information-based tools in doctors’ hands.

14

Radiation beam to the heart
Noninvasive therapy halts arrhythmia in clinical trials.
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New integrated center changes care model for
women and babies.

COVER Early results show a new non-

invasive therapy — delivered in 10 minutes or
less — is halting arrhythmia when standard
treatments have failed. A vest (above), covered
in 252 electrodes, produces a panoramic map
of a patient’s heart. Doctors use this map to
direct a radiation beam at the heart, zapping
malfunctioning cells. See page 14.
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In a well-choreographed move
Jan. 27, staff members transported
babies one at a time — about
10 infants an hour — from the
newborn intensive care unit (NICU)
at St. Louis Children’s Hospital to
the hospital’s expanded NICU.
Now, a 100-foot skywalk connects
the NICU with labor and delivery
in the new Barnes-Jewish
Parkview Tower. See page 20.

As inaugural director of the
Institute for Informatics, Philip R.O.
Payne, PhD, is charting a new path
forward for big data initiatives at
Washington University. See page 7.
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Sylvia, 12, tries on a medallion commemorating a
professorship in her grandfather’s name, while family
members look on. Big sister Mackenzie (background,
center) is joining the freshman class this fall.
The family established the Daniel J. Brennan, MD,
Professorship in Neurology. See page 30.
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Body clock disruptions may be first sign

Changes could ID Alzheimer’s risk sooner — years before memory loss

P

eople with Alzheimer’s disease
are known to have circadian
clock disturbances that affect the
sleep/wake cycle. New research indicates
that such disruptions also occur much
earlier in people whose memories are
intact but whose brain scans show
preclinical evidence of Alzheimer’s.
The findings could help doctors identify
people at risk of Alzheimer’s, a disease that
can take root in the brain 15 to 20 years
before clinical symptoms appear.
The research was published Jan. 29 in
the journal JAMA Neurology.
“It wasn’t that the people in the study
were sleep-deprived,” said first author Erik
S. Musiek, MD, PhD, an assistant professor
of neurology. “But their sleep tended to be
fragmented. Sleeping solidly for eight
hours is very different from getting eight
hours of sleep in one-hour increments.”

2 Washington University School of Medicine

The researchers conducted a separate
study in mice, published in The Journal of
Experimental Medicine, showing that
circadian disruptions accelerate the
development of amyloid plaques in the
brain — a process linked to Alzheimer’s.
Previous studies at Washington
University, conducted in people and in
animals, have found that amyloid levels
fluctuate predictably during the day and
night — decreasing during sleep and
increasing when sleep is disrupted or when
people don’t get enough deep sleep.
In this work, the researchers tracked
circadian rhythms in 189 cognitively normal,
older adults with an average age of 66.
Some had positron emission tomography
(PET) scans to look for Alzheimer’s-related
amyloid plaques in their brains. Others had
their cerebrospinal fluid tested for Alzheimer’srelated proteins. And some had scans and
spinal fluid testing.

Of the participants, 139 had no evidence
of the amyloid protein that signifies
preclinical Alzheimer’s. Most had normal
sleep/wake cycles, although several had
circadian disruptions that were linked to
advanced age, sleep apnea or other causes.
But among the other 50 subjects —
who either had abnormal brain scans or
abnormal cerebrospinal fluid — all
experienced significant disruptions in their
internal body clocks, determined by how
much rest they got at night and how active
they were during the day.
The researchers said it’s too early to
determine whether disrupted circadian
rhythms put people at risk for Alzheimer’s
disease or vice versa.
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Researchers helped mice recover faster from stroke by clipping their whiskers, an
important sensory organ. The above images show brain mapping at eight weeks
post-stroke in mice with whiskers intact (left) and with trimmed whiskers.

Stroke recovery improved
by sensory deprivation
Temporarily shutting off neuronal signals to a healthy
part of the brain may aid stroke recovery, according to
new research in mice.
Mice that had experienced strokes were more likely to
recover the ability to use a front paw if their whiskers were
clipped following a stroke. Trimming the whiskers deprives
an area of the mouse’s brain from receiving sensory signals.
And it leaves that area of the brain more plastic — or
receptive to rewiring to take on new tasks.
“We may have to rethink how we do stroke rehabilitation,”
said senior author Jin-Moo Lee, MD, PhD, the Norman J.
Stupp Professor of Neurology. “Stroke rehab often focuses on
trying to train patients to compensate for disability caused
by the stroke, but this strategy has limited effectiveness.
Our findings suggest that we may be able to stimulate
recovery by temporarily vacating some brain real estate
and making that region of the brain more plastic. One
way to do that might be by immobilizing a healthy limb.”
The researchers triggered, in mice, a stroke in the part
of the brain that controls the right forepaw. Then, they
trimmed the whiskers in half of the mice. Immediately after
the strokes, both groups of mice favored their left forepaws.
But by four weeks after the strokes, those with clipped
whiskers had begun using their right forepaws again, and
by eight weeks, they were back to using both equally. In
contrast, mice whose whiskers were not clipped showed
no improvement at four weeks and only partial recovery
at eight weeks.
Brain mapping revealed that, in each mouse with
trimmed whiskers, the locus of forepaw control had taken
over part of the area that usually receives whisker sensation.
“Maybe we need to start thinking about improving
outcomes by enhancing plasticity in targeted regions of
the brain,” Lee said.
outlook.wustl.edu

A new drug compound — that dials
down inflammation and is more
selective than other compounds
targeting the same inflammatory
pathway — might be useful against
autoimmune disorders such as
rheumatoid arthritis, according to
School of Medicine research.
The protein p38 MAPK helps tissue
remain healthy, but when chronically
switched on, it attacks the body’s own
tissues. Because this protein drives
inflammation in many disorders,
drug companies have developed
compounds to block its signaling.
These compounds work for a while,
but eventually the body recalibrates
and inflammation returns.
Rather than blocking the entire
pathway, the new compound, CDD450, hits just one of several branches
a bit downstream of the p38 MAPK
protein. Blocking that pathway
3D CT scans of rat paws show
while allowing the other branches
(from top to bottom): a normal
to operate freely may remedy the
inflammation recalibration problem. joint; the effects of rheumatoid arthritis; reduced damage
Studying mice, rats and human
after treatment with the drug
cells, the researchers found that
compound CDD-450.
the compound reduces levels of
inflammatory signaling molecules. The scientists further
showed that it prevents the destruction of bones and
joints in a rat model of rheumatoid arthritis.
Developed by Confluence Discovery Technologies Inc.,
the compound is novel because it is not a global inhibitor
of the protein, said Gabriel Mbalaviele, PhD, an associate
professor of medicine and company co-founder.
CDD-450 could be taken by mouth, unlike some antiinflammatory treatments called biologics that must be
injected into the bloodstream. Also, because biologics
are made of short protein sequences, the immune system
may recognize them as foreign and eliminate them,
resulting in resistance buildup. The new inhibitor, a
small molecule, bears no resemblance to proteins.
Aclaris Therapeutics Inc. recently acquired
Confluence and is moving toward clinical trials to test
the safety of CDD-450 (now called ATI-450).
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Drug compound shows
promise against arthritis
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Seven faculty named
2017 AAAS fellows
Seven faculty members are among 396 new fellows selected
by the American Association for the Advancement of Science
(AAAS), the world’s largest general scientific society.
Michael G. Caparon Jr., PhD
Professor of molecular microbiology
Honored for his studies of disease-causing bacteria,
such as those that cause strep throat, scarlet fever
and urinary tract infections.

STANDING IN SOLIDARITY Students joined in
the March 14 walk-out/die-in to remember the victims of the
Parkland, Florida, shooting and call attention to gun violence
as a public health crisis. They also advocated for a stronger
role by the Centers for Disease Control in studying the issue.

No progress seen in reducing
antibiotics among outpatients
Despite public health campaigns aimed at reducing
unnecessary prescriptions, antibiotics continue to be
prescribed at startlingly high rates in outpatient settings,
according to a new study.
The researchers analyzed de-identified data from Express
Scripts Holding Co. and found that 98 million outpatient
antibiotic prescriptions were filled by 39 million people during
a three-year period from 2013 to 2015. They found no decline
in the overall antibiotic prescription rate during that time.
“This study suggests that current guidelines on prescribing
antibiotics are not being followed,” said Michael Durkin,
MD, assistant professor of medicine and co-director of the
Antimicrobial Stewardship Program at Barnes-Jewish Hospital.
The data tracked monthly prescription rates for all
antibiotics, including the five most prescribed in outpatient
settings: azithromycin, amoxicillin, amoxicillin/clavulanate,
ciprofloxacin and cephalexin.
The CDC estimates that up to 30 percent of antibiotic
prescriptions in outpatient settings may be unnecessary, such
as those written for sore throats and sinus infections, which
most often are caused by viruses. Overuse contributes to the
rise of drug-resistant superbugs and excess health-care costs.
The researchers are conducting further studies to understand
the gap between guidelines and prescribing practices.
4 Washington University School of Medicine

Graham A. Colditz, MD, DrPH
Niess-Gain Professor of Surgery and chief of the
Division of Public Health Sciences
Honored for contributions to cancer epidemiology
and prevention.
John A. Cooper, MD, PhD
Professor and head of the Department of Biochemistry and
Molecular Biophysics
Honored for contributions to the field of cell motility and the
cytoskeleton, particularly for actin assembly and function.
Michael S. Diamond, MD, PhD
Herbert S. Gasser Professor of Medicine
Honored for his studies of how viruses such as
West Nile, Zika, dengue and chikungunya evade the
immune system and cause disease.
Susan K. Dutcher, PhD
Professor of genetics and the interim director of the
McDonnell Genome Institute
Honored for contributions to the field of cell biology,
particularly for studies examining the assembly and
function of cilia.
Timothy J. Eberlein, MD
Bixby Professor of Surgery and head of the Department
of Surgery; director of Siteman Cancer Center
Honored as a pioneering, national leader in
surgery education, research and publishing, and
in development of cancer center networks,
research programs and clinical protocols.
Michael L. Gross, PhD
Professor of chemistry in Arts & Sciences and of immunology and
pathology and of medicine in the School of Medicine
Recognized for contributions to physical-organic,
analytical, environmental and biophysical chemistry by
developing and applying mass-spectrometry methods.
Summer 2018
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Wonderfully weird
Students got creepy and kooky, mysterious
and spooky and altogether ooky in their
performance of “The Addams Family Musical”
in March. The production, a culmination of a
yearlong planning process, involved students
from all educational programs on the Medical
Campus. This was the 13th year for the show,
which is entirely student-produced. Students
build sets, sew costumes, run light and sound,
play in the pit orchestra, direct and act. Left:
Uncle Fester, as played by Matt Mosley, a student
in the Division of Biology & Biomedical Sciences.

New way to fight sepsis: Rev up immune systems

S

epsis — a condition that develops
when an infection triggers an
overwhelming immune response —
causes about 250,000 deaths annually in the
U.S. Standard treatment, involving high doses
of antibiotics, often doesn’t work well and
fails to boost the body’s immune defenses.
Now, a drug that revs up the immune
system is showing promise in a small clinical
trial. The approach goes against the grain
of earlier strategies that have relied on
antibiotics and inflammatory medications to
tamp down the immune system.
“Mortality rates from sepsis have remained
essentially the same over the last 50 years,”
said senior investigator Richard S. Hotchkiss,
MD, a professor of anesthesiology, of medicine
and of surgery. “Hundreds of drugs have
been tried and have failed. It may sound
counterintuitive when inflammation is such
a problem early in sepsis, but our approach is
to stimulate certain immune cells to help the
patient’s system take control of the infection.”
The trial involved 27 sepsis patients, ages
33 to 82, who were treated at Barnes-Jewish
Hospital, Vanderbilt University Medical Center
in Nashville or two medical centers in France
— Dupuytren University Hospital in Limoges
and Edouard Herriot Hospital in Lyon.
outlook.wustl.edu

The patients
were treated with
a drug made of
interleukin-7 (IL-7),
which enhances
the proliferation
and survival of
immune cells
CD4 and CD8.
These cells are
important because
they recruit other
immune cells
to fight severe
infections that
can lead to organ failure and death. Patients
who develop the most serious form of sepsis,
called septic shock, often have very low
counts of these key immune cells.
The trial patients, all hospitalized and
severely ill with septic shock, were randomly
assigned to one of two therapies. Seventeen
patients received the IL-7 drug, and 10
received a standard treatment. Those who
received the IL-7 drug experienced a threefold
to fourfold increase in CD4 and CD8 counts.
Traditional approaches do not address
the critical problem of patients’ severely

HUY MACH

Clinical trial demonstrates significant, lasting increase in key immune cells

A small clinical trial led by Richard S. Hotchkiss, MD,
shows that a drug that revs up the immune system
holds promise in treating sepsis. From left, Hotchkiss,
an ICU doctor for the past 30 years, his clinical trial
patient, Greg Porter, who recovered from sepsis, and
nurse manager Jane Blood, RN.
compromised immune systems. Without
restoring immune function, Hotchkiss said,
many patients develop lingering infections
and are helpless to fight any new infections.
A larger trial is being planned to determine
whether IL-7 can improve survival rates.
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EARNING A SPOT STAT, an online biomedical science
news publication, chose 64 teams to compete in STAT Madness 2018,
a March-Madness-esque battle designed to find the most innovative
scientific and medical research of 2017. Two School of Medicine
teams made the bracket, and one of them made it to the “Elite
Eight.” That team, led by Farshid Guilak, PhD (foreground), was
chosen for research aimed at rewiring stem cells to cure arthritis.

American Academy of Arts and
Sciences elects Perlmutter
David H. Perlmutter, MD, dean of the
School of Medicine, will join the likes of
former President Barack Obama, actor
Tom Hanks and Supreme Court Justice
Sonia M. Sotomayor as new members
of the American Academy of Arts and
Sciences.
Perlmutter, the Spencer T. and Ann
W. Olin Distinguished Professor and
executive vice chancellor for medical affairs, is internationally
recognized for his research on alpha-1 antitrypsin deficiency
(ATD), a genetic disorder in which the accumulation of a
misfolded protein in liver cells can result in severe liver failure.
To evaluate potential treatments for ATD, he and
colleagues developed a pipeline of drugs that includes one
in a phase II/III clinical trial. The goal is to eliminate the
need for liver transplantation, the only treatment option
for patients with progressive liver disease due to ATD.
Perlmutter was trained at Children’s Hospital of
Philadelphia and Boston Children’s Hospital and has
been on the faculties of Harvard Medical School and the
University of Pittsburgh.
The new class will be inducted in October in Cambridge,
Massachusetts, joining a list that includes Benjamin
Franklin, Alexander Hamilton, Ralph Waldo Emerson,
Charles Darwin, Albert Einstein and Martin Luther King Jr.
6 Washington University School of Medicine

Last year, the Food and Drug Administration approved
the first cellular immunotherapies to treat cancer. These
therapies involve collecting a patient’s own immune cells
— called T cells — and supercharging them to home in on
and attack specific blood cancers, such as hard-to-treat acute
lymphoblastic leukemia and non-Hodgkin lymphoma.
But so far, these T cell immunotherapies — called CAR-T
cells — can’t be used if the T cells themselves are cancerous.
Even though supercharged T cells can kill cancerous T cells,
they also can kill each other because they resemble one
another so closely.
School of Medicine
scientists now have
used the gene-editing
technology CRISPR
to engineer human T
cells that can attack
human T cell cancers
without succumbing
to friendly fire.
The study in mice
appears online in the John DiPersio, MD, PhD, right, works in the lab
journal Leukemia.
with study co-author Armin Ghobadi, MD.
Cancerous and
healthy T cells have the same protein — CD7 — on their
surfaces. The team, led by senior author John F. DiPersio,
MD, PhD, the Virginia E. and Sam J. Golman Professor of
Medicine in Oncology, first generated a novel CAR-T strategy
targeting CD7, allowing for the targeting and killing of all
cells with CD7 on the surface.
“But if we program T cells to target CD7, they would
attack the cancerous cells and each other, thus undermining
this approach,” DiPersio said. “To prevent this T cell
fratricide, we used CRISPR/Cas9 gene editing to remove
CD7 from healthy T cells, so they no longer carry the target.”
DiPersio and his colleagues also used CRISPR to
simultaneously eliminate the therapeutic T cells’ ability to
see healthy tissues as foreign.
This way, T cells from any normal donor can be used
without risk of life-threatening toxicities such as graftversus-host disease. A “matched” donor with similar
immunity is not required.
This new approach also may have broad implications for
the CAR-T field, allowing for use of therapeutic T cells from
any healthy donor.
The researchers demonstrated that this approach is
effective in mice with T cell acute lymphoblastic leukemia
taken from patients. They are working toward clinical trials
of the gene-edited CAR-T cells.
Summer 2018
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CRISPR enhances
cancer immunotherapy
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BIG DATA
Putting information-based tools in doctors’ hands
B Y D E B PA R K E R
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The Institute for Informatics
— also known as I2 —
sits at the center of all
big data initiatives at
Washington University.
It provides an academic
and professional home
for informatics science,
education and practice.

Genomic medicine. Personalized
medicine. Precision medicine.
When it comes to interpreting and applying big data in health care,
people may not agree on the best terminology. Most agree on one
thing: Big data is an abstract, intimidating concept.
DNA sequencing generates millions of data points for a single individual.
Clinical trials yield massive amounts of treatment information. The
electronic health record (EHR) expands with every patient encounter.
And wearable fitness trackers and apps — which measure steps taken,
food consumed, heart rate, blood pressure and sleep patterns, open up
a whole new area of possibility.
Big data is coming at medical professionals from all directions.
Many have no idea how to effectively leverage it for patient care.
Philip R.O. Payne, PhD, is an internationally recognized leader in
informatics, a field that translates big data into actionable knowledge.
As inaugural director of the university’s Institute for Informatics, he
leads the way he speaks — at double speed. In 20 months of existence, the
institute has made significant inroads at this large, decentralized university.

8 Washington University School of Medicine
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For Payne, the path forward is clear.
“If you ask physicians what they want, it’s
the equivalent of a ‘patients like mine’ button on
their electronic device,” he said.
“They tell us, ‘Given the patient that’s in front
of me right now, show me similar patients who
have been seen in the past six months, one year
or 10 years. What treatment decisions were made?
Who had the best outcomes? Who didn’t?’
“Physicians want to know, based on their
wisdom and the wisdom of colleagues, how to
optimize outcomes for the patient in front of them.”

Information overload
Provider burnout nationally is at an all-time high,
with doctors citing such factors as job complexity and
having too few hours in the day. By some estimates,
EHR upkeep requires 31 percent of physicians’ time.
A few decades ago, doctors could stay abreast
of medical advances by reading scholarly journals.
Now, it’s virtually impossible to keep up with the
constant flow of information.
“Human short-term memory is optimized to
remember seven pieces of information at a time,
plus or minus two,” said Payne, also the Robert J.
Terry Endowed Professor. “Informatics is essential
to figuring out how we connect the dots between
those millions of data points, contextualize them
and deliver them back to clinicians who may have
only 10 minutes with a patient to interpret and act
on that information.”

Payne envisions a new landscape — where
doctors and researchers have the necessary tools
and expertise to extract meaningful information
within vast data sets.
When many people hear the word informatics,
Payne said, they associate it with interpreting the
human genome, but that’s just one aspect of the
institute’s work.
A top priority is improving EHR efficiency.
The EHR requires a mental shift for some physicians
who are used to free-form documentation of
patient encounters on paper versus a more rigid,
checkbox system that perhaps even influences
medical thinking. Many clinicians find it clunky,
burdensome and disruptive. Institute team
members are shadowing clinicians at the point of
care to design technologies that adapt to workflow.
Efficiently designed systems can close the gap
between digesting the data and making clinical
decisions, Payne said. “The real challenge is not
getting more data. It’s figuring out what to do
with what we already have.”
Recently, Payne and David H. Gutmann, MD,
PhD, the Donald O. Schnuck Professor and director
of the Neurofibromatosis (NF) Center at Washington
University, employed informatics to predict
symptom severity in children with NF1, a genetic
disorder that causes brain and nerve tumors, as well
as autism spectrum disorder (ASD). NF1 varies
widely in severity and symptoms — from harmless
brown spots on the skin and benign bumps to optic
gliomas and malignant cancers. Parents don’t know
which symptoms might manifest in their child.

MATT MILLER

The institute is actively
training the next generation
of informatics specialists.
Here, Andrew Michelson, MD,
left, a pulmonary and
critical care fellow, and
Sean Yu, a biomedical
informatics doctoral student
in the Payne-Lai lab, discuss
analytical methods to
predict septic shock.
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A data-driven approach, Payne said, is going
to be a key differentiator as institutions compete
to provide exceptional care in an informationrich era. Within its storehouses, big data holds
the answers to pressing medical questions of our
time; it has the power to develop drugs faster at
lower cost, speed diagnosis, deliver on the
promise of personalized, or precision, medicine,
and improve quality of life.

A home advantage
Harnessing this power requires an environment
that’s built to rapidly translate discovery out of
the lab and into the clinic.
Washington University, in partnership with
BJC HealthCare, stands uniquely poised to lead
on the informatics frontier, with key strengths in
medicine, basic science, cancer, genomics,
radiology, public health, social work, business
and engineering, among others. Nearby sits the
200-acre Cortex Innovation Community, a
thriving hub for bioscience research,
development and commercialization.
“We have one of the best genome institutes
and one of the most productive and most
impactful basic science research enterprises
in the world,” Payne said. “We have some of
the smartest care providers that you will meet.
We have a unique living laboratory between
Washington University Physicians and
MATT MILLER

In a matter of hours, using computer analytics
and existing NF1 patient data, Gutmann and
Payne improved risk models that others had
created following months of painstaking
deliberation in conference rooms. With even
greater specificity, they outlined various NF1
subtypes, their trajectories and associations with
optic gliomas and ASD.
This information allows families to plan ahead,
and alerts clinicians as to whether additional
imaging or other interventions are warranted.
“Precision medicine isn’t always about curing,”
Payne said. “We can improve quality of life by
illuminating the unknown. It’s also helpful for the
clinician in the exam room, who is facing imaging
reports, EHR data, gene sequencing results, maybe
a social/behavioral evaluation report — and an
anxious child and an anxious parent. We are
relying on physicians to integrate on demand and
make the best possible decision. That’s a source of
stress for providers, who have limited time and an
EHR that isn’t designed very well.
“But if we can integrate that data and say to
those providers, ‘This patient has an 80 percent
probability of developing an optic glioma and here
are the outcomes for the last 10 children you saw
similar to this,’ then we’ve allowed them to get
down to the really important information and
have a conversation with the family and not just
sit there clicking and pointing and typing.
“That’s the real promise if we do all the things
we’re talking about.”

“Precision medicine isn’t
always about curing.
We can improve quality
of life by illuminating
the unknown.”
—Philip R.O. Payne, PhD

10 Washington University School of Medicine
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BJC HealthCare, where we have a large academic
referral center, plus regional hospitals and primary
care practice sites in urban and rural environments.
“We have all the pieces we need to study what
the future of health care looks like. Very few U.S.
academic health centers are truly primed to take
advantage of the health-care information age.”
Until the institute’s launch, the university had
all the raw pieces, except one. Although pockets
of informatics strength existed — including
leadership in the Human Genome Project, the
Connectome Project and efforts to understand
the microbiome — there was no central academic
and professional home for informatics science
and practice.
Every School of Medicine department chair
contributed funding from department reserves
to establish the Institute for Informatics, also
known as I2.

One patient, one record
After putting critical team members in place,
institute leaders turned their attention to their
first, most fundamental task: Getting everyone
within this expansive, 15-hospital system and
medical school on the same page.
This June, with the institute’s active
participation, the medical school and BJC
HealthCare will roll out the Epic electronic health
record system on the academic campus. It already
has been launched in many of BJC HealthCare’s
community hospitals. Once fully implemented,
Epic will replace more than 50 standalone EHR
systems that had been used by individual
physician groups, specialty clinics, hospitals and
even departments within the hospitals. Previously,
outpatient data generated through Washington
University Physicians (faculty practice plan) was
not connected to hospital inpatient data. And
some records were still paper-based.
As Sam Bhayani, MD, chief medical officer
of Washington University Physicians, explains,
the medical center draws patients who live hours
away and who have complex problems and see
multiple specialists.
Bringing data into one centralized location
eliminates the need for patients to recall their
entire medical history, such as the date of their last
tetanus shot or prescription dosages, and will reduce
treatment redundancies, potentially saving money,
and help eliminate harmful drug interactions. It also
allows clinicians to view patients holistically and
outlook.wustl.edu

Launching
the institute

W

hen Philip R.O. Payne, PhD, previously chair of the
Department of Biomedical Informatics at The Ohio State
University, signed on to become the institute’s founding director,
he brought longtime colleagues with him.
This allowed for rapid deployment in targeted areas:

• Speeding pace of discovery out of the lab into human studies
• Building systems that improve how physicians treat patients
• Using data to improve health of communities
Most faculty affiliated with the institute, which is housed in the
Division of General Medical Sciences, will hold dual appointments
in other departments and schools. This is part of a strategy to
extend the institute’s reach across the university. An informatics
expert embedded in anesthesiology or pediatrics, for example,
will collaborate on projects related to these subjects.

Key informatics faculty investigators
Clinical research informatics
Chief Research Information Officer
Albert M. Lai, PhD, an expert in informatics
infrastructure who specializes in solving
problems in the clinical domain. He oversees a
core services team of programmer analysts,
software engineers, database administrators,
data analysts and bioinformaticists.

Population health informatics
Randi Foraker, PhD, MA, FAHA, who applies
informatics techniques to solve problems
in the population health domain. She also
serves in the Institute for Public Health.

Applied clinical informatics
Po-Yin Yen, PhD, RN, an assistant professor
at the Goldfarb School of Nursing at BarnesJewish College, who works with frontline
caregivers to understand daily workflow and
improve health information technology.

Outlook 11

When data becomes treatment
SOURCES

METHODS
R
D
C

Sources
Data is generated
through the EHR,
clinical studies, genome
sequencing and patientreported outcomes,
among other sources.

OUTPUT

Methods
Data is integrated in the
Research Data Core, a centralized
warehouse managed by statistical
data analysts. Here, various
approaches can be used to
analyze data — from machine
learning to visualization.

Output
From this analysis, decision-support
tools can be designed to assist
physicians at the point of care.
These tools — such as reminders
for preventive care or alerts about
potentially dangerous situations —
can be deployed through laptops,
tablets and mobile phones.

Impact
Precise, knowledge-based interventions
benefit doctors, researchers, patients,
communities and policymakers.

12 Washington University School of Medicine
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consider all factors
across the continuum
of care. What should
emerge is a more
comprehensive picture
of a person’s health care,
including total cost of care.
This, however, is only
half of the vision. Patient
information must be returned
back to investigators as they
consider new ways to solve
complex health-care problems.
Data mining within a
decentralized system has been
an arduous, inefficient task.
“For some patients, we had
very little data. All we knew is
what happened during their hospital
stay,” said Chief Research Information
Officer Albert M. Lai, PhD. “If you’re
a researcher trying to understand
optimal care delivery, it’s basically
impossible given this fragmented view.”

A new research paradigm
A centralized EHR has revolutionary research
implications for Washington University —
joining together and unlocking access to
more than 6 million records of inpatient and
outpatient care.
“We want to translate data into knowledge,”
Payne said. “We want to create a system where
what we learn from each patient informs how we
treat other patients and what questions we ask in
the lab. In turn, we want what we learn in the lab
to benefit patients more quickly.
“Right now, we have clinical investigators
seeing patients. But they go back to their labs
and they don’t have access to the data generated
by their own patients, at least not to the degree
necessary to test basic hypotheses. We need to
make that data more accessible.”
The real forward leaps in innovation will
come as the institute builds out a large, integrated
database — known as the Research Data Core
(RDC) — that links all data. The RDC powerhouse
will include the common EHR, which feeds a
continuously updated stream of patient data, plus
data from any remaining legacy or departmental
clinical systems. Plans call for the addition of
genomic and biospecimen information.
Summer 2018

Statistical data analysts within the institute will
manage the RDC. These informatics professionals
will help researchers pull data from the central
system, design studies and maintain patient
confidentiality. They and other team members are
available to educate, answer questions and analyze
and visualize data in meaningful ways.
Through self-service tools, researchers will be
able to access the RDC and do some analysis at
their own computers.
Informatics leaders say a new partnership with a
company called MDClone also has the potential to
fast-track research. Washington University is the first
U.S. academic institution to have this technology.
Under current federal regulations, investigators
must wait weeks or months to begin research
projects involving real patients. For each project,
researchers must file paperwork and wait for
approval from an institutional review board (IRB),
an administrative body that protects the rights
and welfare of human research subjects. Following
approval, researchers then must wait for a data
analyst to pull the necessary data before research
can get underway.
MDClone’s unique niche is its ability to create
synthetic data — data that looks like an actual patient
population, but isn’t. Data engines yield synthetic
data that is statistically identical to original protected
health information, but without privacy concerns.
“With MDClone, you could effectively have no
time delay,” Lai said. “If you think of an idea, you
can pull up the data and analyze it, right then and
there, from the computer in your office, potentially
make discoveries on the data, with zero risk to
patient privacy.”
If the data looks promising, researchers can
follow the standard IRB steps to confirm the
result with real data. If not, Lai said, they can
just move on to the next question.
The institute is testing MDClone’s performance
via pilot research projects. Pending a successful
evaluation, MDClone will become part of the
RDC infrastructure.
Creating efficiencies in research saves time and
allows grant dollars to stretch farther, Payne said,
which, in turn, will attract top U.S. researchers.

Speeding discovery
Payne hopes to speed up the process of taking
discoveries into clinical trials. Currently, it can
take 15 to 20 years and more than $1 billion to
develop therapeutic agents for disease.
outlook.wustl.edu

Treatment solutions, however, are waiting
to be found in big data. Repurposing or using
new combinations of approved drugs, which already
have passed toxicity tests, could save valuable time.
Using an informatics concept known as
“machine learning,” computers can be
programmed to comb through clinical and
drug data, going back through decades of
medical literature, analyzing billions of variables,
to discover meaningful patterns and new uses for
existing medicines.
Payne, also a cancer researcher, points to
malignant melanoma as one example. Frontline
therapies are effective at causing tumors to
disappear, but patients often become resistant
within 12 months of the first treatment. By
using public data and computational methods,
researchers have found drugs — developed for
other diseases — that could be combined with
melanoma frontline therapies to prevent or delay
resistance onset. So far, Payne’s research team has
taken this combination therapy all the way to
animal models, and they did it in about a year.
Once a therapeutic agent is ready to move to
clinical trials, the RDC also should make it
quicker and more efficient to identify test subjects.

Enhancing human health
The dream, Payne said, is to use big data not only
to help the sick, but also to keep people well, to
intervene in the communities where they live,
work and play, and not just inside our hospitals.
An evolving EHR likely will include more data
about patients’ daily activity levels, gathered
through smartphones and fitness trackers, and
other health influencers, such as water quality in
the home, proximity to grocery stores and family
support networks.
Big data has the power to promote wellness
by generating a picture of the whole patient —
connecting genes and environmental factors to
social factors and outcomes.
“The institutions that figure out how to bring
all these pieces together will be the first to begin
delivering personalized, precision medicine,”
Payne said. “Rather than treating people as a
function of averages, personalized health care
that is powered by big data is about enabling
physicians to provide the right care at the right
time, based on the unique characteristics of the
patient in front of them.”
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Radiation beam
to the heart
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Doctors halt deadly rhythm
with noninvasive therapy
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SARA MOSER

BY REBECCA BOYLE

n the early days of his irregular heartbeat,
Clarence Mankin would pass out before his
implanted defibrillator kicked in to reboot his
heart. He would wake up a bit later, dazed but alive.
After his doctor adjusted the device’s sensitivity, it
would shock his heart before he fainted, which, in
some ways, was worse. Mankin could feel it coming —
the lightheadedness, the dizziness — and he’d know
to brace himself for the jolt.
“It’s like a good thump in the chest. It feels like
you are going to die,” he said. “I’d try to grab hold of
something, or find something to sit down on, which
occasionally I was able to do.”
Mankin, 74, a retired Lutheran pastor in Atlanta,
Illinois, used to pride himself on walking 10,000 steps a
day, which he tracked with his wrist pedometer. But when
he started feeling the jolt all the time — at one point, he
was having 11 episodes a day — he stopped walking.
He stopped driving.
He stopped leaving the couch.
About 3 million Americans experience arrhythmia,
in which the heart beats too fast, too slow, or too
irregularly. One such form, ventricular tachycardia,
is the leading cause of sudden cardiac arrest.
An unlikely pairing between a School of Medicine
cardiologist and a radiation oncologist, however, has
led to a revolutionary treatment: Mankin is one of the
earliest patients to sustain a beam of radiation directly
to his heart.

Outlook 15

V

To treat arrhythmia,
cardiologist Phillip S.
Cuculich, MD, performs
catheter ablation. For
this procedure, the patient
must be sedated as Cuculich
threads fine catheters
through the femoral vein,
up into the heart, to burn
away malfunctioning cells.

entricular tachycardia (VT) results
from other cardiac problems. Mankin,
who served in the U.S. Army during
the Vietnam War, had his first heart attack at 44,
which he attributed to Agent Orange exposure.
Injury to the heart, commonly from a heart attack,
causes some cells to die, forming scar tissue. When
heart cells are damaged in this way, they might
not function correctly, causing the heart to shortcircuit. This makes it beat out of sync, which means
the heart might not be able to pump enough blood
throughout the body, and it can even stop entirely.
Standard treatments include medications,
defibrillators and a procedure known as catheter
ablation. Patients must be sedated for this invasive
procedure as doctors thread fine tubes through
the femoral vein, up into the heart. A tiny electrode
tip, no larger than a headphone jack, selectively
burns away heart cells that have gone haywire.
The procedure can last from four to 10 hours,
and recovery can take several weeks. Although
physicians have developed precise ablation
techniques to ensure they destroy as many
wayward cells as they can, the treatment doesn’t
always work. It also has a cluster of side effects,
from infections to bleeding problems. In a 2016
study, half of patients who underwent catheter
ablation saw their tachycardias return.
The same was true for Mankin.
Then Mankin’s cardiologist referred him
to Phillip S. Cuculich, MD, a heart rhythm
specialist and an associate professor of medicine
at Washington University.

Cuculich and Cliff G. Robinson, MD, an associate
professor of radiation oncology, recently had teamed
up to provide a new type of arrhythmia treatment,
one that cardiologists nationally are calling a game
changer for patients with few remaining options.
Mankin agreed to give it a try.
To undergo the procedure, he donned a specially
designed vest covered in 252 electrodes (as compared
to 12 for a typical electrocardiogram).
Then Cuculich briefly induced VT in Mankin
using his defibrillator. This allowed him to
produce a panoramic map of Mankin’s heart.
Later, Mankin lay inside a cylindrical chamber.
A custom mold held him in place to prevent him
from moving or breathing too deeply. Robinson
used the map to direct an intense, focused beam
of radiation at his heart.
The high-energy particle stream is typically
used to blast away cancer cells, and, during normal
use, Robinson does everything he can to avoid
hitting the heart. But this time, his particle beam
intentionally zapped malfunctioning cells that
were causing Mankin’s heart to beat out of sync.
On average, the procedure takes less than
15 minutes.
“I’ve spent my entire life as a trainee and an
attending physician thinking about ways to avoid
dosing healthy tissues,” Robinson said. “But this is
already an injured region. If you think about it as
a diseased part, where Phil would have no problem
going in with a catheter to burn that area, well, we
are doing the same thing. There are other ways to
get energy inside the body.”

Catheter
Ablation

Noninvasive
Radiotherapy

4–10

< 10

hour procedure

minute procedure

2 days

25 minutes

in the hospital

40–70%
success rate
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2–12%

complications
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door-to-door

TBD

Success rates and
complication rates
are being evaluated
in clinical trials.
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Mankin was awake throughout the radiation
therapy, which took place Sept. 8 at Barnes-Jewish
Hospital. When it was over, he sat up, swung his
legs off the table, and walked out of the room.
He felt no pain.
On a warm January day, Mankin visited
Cuculich’s office for a follow-up appointment.
Cuculich downloaded data from his implantable
defibrillator, which tracks each time it gives
Mankin a jolt. After the appointment, Cuculich
printed out the device’s history on a piece of paper,
and strode into Robinson’s office in the radiation
oncology department.
“Look at this,” Cuculich said, grinning as he
thrust the small square paper into Robinson’s hand.
Robinson’s eyes widened: “Wow!” And then the
oncologist, still seated in his chair, started dancing.
The sheet of paper was marked with what
looked like a bar graph. The bottom axis was time,
and the vertical axis depicted every instance the
device was activated.
Cuculich pointed out the three months prior
to the Sept. 8 radiation treatment. It looked like a
forest: A spike each day, some very tall and some
shorter, referencing the number of jolts each day
from the device. Then Cuculich pointed to Sept. 8,
and the months after Mankin’s procedure. The
forest had been cleared. The device had not activated
at all. The tachycardia was gone.
Cuculich and Robinson both laughed.
“That is amazing,” Robinson said.
outlook.wustl.edu
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V E N T R I C U L A R TAC H YC A R D I A

A vest covered in 252
electrodes allows Phillip
S. Cuculich, MD, center, to
produce a panoramic map
of a patient’s heart. Cliff G.
Robinson, MD, right, uses
this map to direct a focused
beam of radiation at the
heart to treat arrhythmia.
Biomedical engineer Yoram
Rudy, PhD, invented the vest.

More than three months later, Mankin hasn’t
had a single jolt from his defibrillator. By February,
he was walking 5,000 steps a day. “It’s hard to
describe. Now when I walk, I don’t feel like
something terrible is going to happen to me,”
Mankin said. “I don’t know if this will extend
my life or not, but it has made the quality of
my life much better.”

When no other options exist
Mankin is one of about two dozen patients
enrolled in a clinical trial led by Cuculich and
Robinson. The ENCORE-VT trial follows an
initial case study from April to November 2015
with just five patients, which the physicians
conducted to prove their technique would work.
The results were published in The New England
Journal of Medicine in January.
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Cliff G. Robinson, MD, and
Kim Maserang, RT (T),
prepare to treat a patient
with stereotactic radiation,
a very precise, high-energy
dose of radiation.

Like Mankin, all patients so far have had
ventricular tachycardia that has not responded
to standard treatments.
In the first clinical trial, the five patients
collectively experienced 6,577 episodes of
VT in the three months before their radiation
treatment. In the nine months afterward, they
experienced four.
“It has the potential to benefit a substantial
number of people,” said William G. Stevenson,
MD, professor of medicine at Vanderbilt University
Medical School, who was not involved in the research.
Cuculich spent several years refining techniques
to map the heart in four dimensions — the three
physical dimensions, plus time — to nail down
the precise regions that are malfunctioning. The
technique, known as electrocardiographic imaging,
was developed by Yoram Rudy, PhD, the Fred Saigh
Distinguished Professor of Engineering, director of
the Washington University Cardiac Bioelectricity
and Arrhythmia Center, and Cuculich’s mentor.
But a more detailed picture of heart dysfunction
was not enough, Cuculich said.

“ We have created an entirely noninvasive process to map and treat
arrhythmia, and we can do it in less
than 10 minutes.”— Cliff G. Robinson, MD
18 Washington University School of Medicine

“Even if you could non-invasively image the
heart, we still required entry into the body with a
catheter to fix it,” Cuculich said. “It became clear
that the place to make an impact was to noninvasively treat it.”
As part of the School of Medicine’s focus
on translational research, Cuculich met with
neurosurgeon Albert H. Kim, MD, PhD, to
discuss using ultrasound technology. Kim
recommended Cuculich meet with Robinson.
For his part, Robinson was looking for new
ways to use stereotactic radiation — a very
precise, high-energy dose of radiation — beyond
cancer treatment.
“When we first met to discuss this, I was
really concerned about how to hit a 5 mm area
in a moving, beating heart,” Robinson said.
“But Phil’s first question was, ‘How big of an area
can you treat?’ And I said, ‘This is going to be a
good friendship.’ Because as radiation oncologists,
we don’t treat parts of tumors. We treat the whole
kit and caboodle.”
Cuculich and Robinson started meeting
regularly to discuss each other’s specialties and
learn about their patients. Each had to relearn
terminology and techniques he hadn’t studied
since medical school.
“That was one of the keys to this initial success,
that we came together and talked about it,” Robinson
said. “That this could happen is one of the unique
things about being at Washington University.”
The physicians developed a technique that
relies on multiple imaging methods. MRI, CT
Summer 2018

and PET scans combine with the electrode
vest to produce a detailed map of the heart and
pinpoint where arrhythmias are coming from. The
imaging process involving patients takes several
hours, occasionally spread over multiple days.
“Then Cliff and I sit down together and
collaborate over this information, and we come
to a conclusion about where the scar is, so we
are as precise as possible. We want to avoid any
structures that are important to the heart, and
keep the potentially damaging energy within the
scar,” Cuculich said.
To Robinson, that push and pull — how deep
to go, how much tissue to take and how much to
leave alone — is much like cancer treatment. Some
patients, like Mankin, have large areas that must be
treated. The burning tip used in catheter ablation is
only about 3.5 millimeters across, roughly the size
of a Sharpie tip. In some people, the cells that cause
the heart to beat out of sync are not reachable with
the tiny catheter tip. This is especially true for cells
deep within the heart muscle. The radiation beam
can penetrate deeper, targeting all the faulty cells.
Robinson said he was concerned some patients
would be fearful of the word “radiation,” but
both physicians said their patients have been
less resistant than they expected, in some cases
because they were desperate for any solution.
Mankin said the doctors helped him understand
how it would work, and why it could be so
effective. “It’s novel, but if you think about it,
they’ve been using the gamma knife on cancer
surgeries for years now,” he said.
With such a high dose of radiation, even at a
very small site, there is a risk of toxicity and ill
effects on the surrounding organs and tissues. So
far, patients in the initial study and in the ongoing
clinical trial have done well, Robinson said. In the
initial study, patients reported no complications
or pulmonary symptoms during treatment or
immediately after. Some people did experience
mild inflammation in the lung adjacent to the
target, but that resolved within a year, according
to the study. Still, the potential long-term effects
of the radiation dose are unknown.
“If this is to be used in younger, less-ill
patients, the issue of collateral damage will
become more relevant,” said Roy John, PhD,
professor of medicine at Vanderbilt University
Medical Center. He and Stevenson coauthored an
editorial explaining the procedure’s potential in
The New England Journal of Medicine.
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Radiation therapy likely will complement,
rather than replace, ablation and other procedures
cardiologists have used for many years. It provides
another option for VT patients who have exhausted
standard therapy options, including catheter
ablation, and are facing one-year survival rates
below 20 percent.
“When you get complex forms of heart
disease that are responsible for a lot of complex
circuitry, then there might be an advantage to
an approach that is more extensive, rather than
precise,” said Francis Marchlinski, MD, director
of cardiac electrophysiology at the University of
Pennsylvania, who was not involved in the study.
Robinson and Cuculich are finalizing their
results from the ENCORE-VT trial, which included
18 patients along with Mankin. Early results, they
say, are promising.
“We have created an entirely non-invasive
process to map and treat arrhythmia, and we
can do it in less than 10 minutes,” Robinson said.
“This approach can fundamentally change the
way we approach these heart rhythm problems.”

Top: This image is a fusion
of a CT simulation scan and
PET/CT. The PET/CT shows
viable heart tissue, outlined
in pink, as a structure to
avoid with radiation. The
red line is the target area.
The green and cyan lines
mark safety margins to
account for motion (patient
breathing and heart beat).
Bottom right and left show,
respectively, the coronal
view and sagittal view.
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Holly and Ben Allen welcome
their new baby, Max, in the
Women & Infants Center.
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Critical
connections
New integrated center changes
care model for women and babies

MATT MILLER

BY KRISTINA SAUERWEIN
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A new center on the Washington University Medical
Campus is transforming health care for women and
babies in the region. The Women & Infants Center is
housed within two 12-story inpatient towers recently
built by BJC HealthCare: the Barnes-Jewish Parkview
Tower and a St. Louis Children’s Hospital tower. A
skywalk connects the labor and delivery areas in the
Parkview Tower with an expanded Level IV newborn
intensive care unit (NICU) in Children’s Hospital,
drastically reducing the time it takes to transfer
critically ill newborns.
The center combines the most advanced facilities
— allowing specialists to perform surgeries in the
womb or manage risky deliveries — with beautiful,
restful, comfortable spaces for patients.
“Women and infants remain at the center’s heart.
It’s as good as it gets,” said George Macones, MD,
head of the Department of Obstetrics and Gynecology.
Other tower floors significantly enhance and
expand inpatient cancer care and pediatric care.
The improvements stem from a three-year design
planning process involving input from nearly 800
health-care workers, patients and family members.
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MONITORING SYSTEM
Cameras are positioned over bassinets
in the OR and areas where medical
staff attend to newborns. The cameras
let mothers watch their new babies
even when they’re not holding
them. This is especially helpful for
C-sections or multiple births.

OPERATING ROOM SIZE
As many as 40 medical
professionals can work in the
largest operating room, which
is designed for emergencies,
for complex operations such
as in-utero surgeries or for
multiple births.

WO M E N’S
ASSESSMENT CENTER
This area allows women who
think they may be in labor
or who have an emergency
gynecological issue to bypass
the emergency room. Specialists
who handle women’s health
issues are on call and can
quickly make an assessment.
22 Washington University School of Medicine

CO M M A N D C E N T E R
In the command center,
nurses, doctors and other staff
can monitor vital statistics for
patients in labor or undergoing
surgery. The stations monitor
18 labor and delivery rooms
and three ORs in real time.
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Caring for mom

M

others-to-be who deliver at the Women & Infants
Center do so in an environment equipped with the top
medical expertise and technology to treat serious conditions
that may affect a pregnant woman or fetus. Barnes-Jewish
Hospital annually cares for about 700 women from eight
states who need specialized obstetric care for deliveries
involving multiple births, pregnancy
complications, fetal abnormalities and
congenital defects in utero.
The labor and delivery floor has three
operating rooms, including one for
maternal-fetal surgeries that is stateof-the-art and spacious enough to
accommodate up to 40 health-care
workers. “This is the room where we do
“It’s one stop
procedures on a fetus while still in the
for women’s
womb,” said George Macones, MD, the
Mitchell and Elaine Yanow Professor and health.”
head of the Department of Obstetrics
George Macones, MD
and Gynecology. “Having extra space is
critical. One procedure, for instance, may include physicians
and nurses from obstetrics, fetal medicine and anesthesia.”
Altogether, 3,300 babies were born last year at Barnes-Jewish
Hospital. The center offers 52 private obstetric rooms, in addition
to 18 labor and delivery rooms. The rooms have sleeper couches
for family, ample outlets for charging electronics and built-in
storage stocked with supplies for diapering and feeding. Android
tablets installed on over-the-bed tables make it easy for the
patient to contact the doctor, order food and access the internet.
The center’s care extends to all women with the new, 12-bed
Women’s Assessment Center, which allows OB-GYN patients
to bypass the general emergency room to receive treatment for
ovarian cysts, hysterectomies and other conditions.
“We take care of women in all reproductive phases,”
Macones said. “It’s one stop for women’s health.”

The three new operating rooms bring
together advanced technology, medical
efficiencies and a focus on patients.
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PAT I E N T RO O M

WO M E N’S WA L K

Spacious, private rooms have
windows overlooking Forest Park
or rooftop gardens. The rooms are
divided into three zones: space
for family members to visit or
spend the night; a place for mom
and baby to rest; and areas that
allow clinicians to do their work.

This hallway was created for
laboring women, so they won’t
have to walk heavily trafficked
areas. Glass walls let in natural
light, illuminating work from
Midwestern artists. Rails and
benches are available for those
who need a hand or a break.
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MSTUDIO WEST

PROTECTIVE EQUIPMENT
Even basic things like how often
protective gowns are restocked
can make a difference in health
care. Cabinets designed to hold
personal protective equipment
(PPE), such as gloves and gowns,
are in consistent locations and
require refills only once daily,
minimizing noise and traffic.

COMMUNICATION TOOL

S KY WA L K
A skywalk links the Barnes-Jewish
Parkview Tower and Children’s
Hospital. Before this skywalk,
any trip between delivery rooms
and the NICU — for newborns or
mothers — required a quarter-mile
journey through corridors and up
and down elevators. Now the trip
takes seconds.
24 Washington University School of Medicine
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Caregivers wear badges that
show their location in real time
and record when they enter
and leave rooms. When in need
of immediate assistance, they
can press the badge to send
an emergency alert. In rooms
with TVs, the badges trigger a
display of the name, title and
photo of doctors and nurses to
help patients know who’s who.

NICU
The newborn intensive care unit
is designed for families. Private
rooms promote bonding and
breastfeeding, and sleeper sofas
and lockers make it easy for
moms and other family to visit.
Mothers can pump breast milk
in private spaces and store it in
in-room refrigerators.
Summer 2018

INROOM CHARTING AND CARE BOARD
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The remodeled and expanded newborn intensive care unit
(NICU) will hold 150 beds when the expansion is complete.
The NICU design was informed by the latest neonatal care
research, including studies on the importance of avoiding
loud noises. The ceilings and flooring reduce noise. Private
rooms cut down on infection.

NICU ECMO
The NICU is equipped to provide
extracorporeal membrane
oxygenation, or ECMO, in which a
machine oxygenates the blood of
infants who can’t breathe on their
own. Children’s is one of the few
hospitals in the Midwest with the
expertise to use this technique.
outlook.wustl.edu

Best for baby

S

econds count when treating a critically ill newborn.
Before the center opened, health-care workers transporting
an infant had to walk one-fourth of a mile from labor and
delivery to the NICU. Now, physicians, nurses and family
members have immediate access to the baby, thanks to the
110-foot skywalk connecting the two hospitals.
“We can’t afford to waste any time after
the mother gives birth,” said F. Sessions
Cole, MD, the Park J. White, MD, Professor
of Pediatrics, executive vice chair of
pediatrics and chief medical officer at
St. Louis Children’s Hospital. “The skywalk
allows us to treat babies immediately so we
can provide the best care possible.”
The expanded NICU offers 37 private
“ We can’t afford
rooms, two of which accommodate
to waste any
multiples, bringing the total number of
time.”
NICU beds to 125. The short skywalk
jaunt from the postpartum rooms also
F. Sessions Cole, MD
promotes mother-baby bonding. “We
include the mom as part of the infant’s health therapy,” said
Cole, director of the Division of Newborn Medicine in the
Department of Pediatrics. “Babies whose moms hold and talk
to them often experience better health outcomes. For example,
babies born with opioids in their system may experience less
irritability and physical discomfort when moms hold them.”
Intertwining mom in a baby’s health-care plan also
means encouraging self-care, a feat made easier because
medical appointments for postpartum mothers are in the
center. “This eliminates obstacles to health care such as
transportation,” Cole said. “Many moms put all their energy
toward their babies and neglect themselves. But a well-cared
for mom makes for a happier baby.”
The expansion also adds 96 private patient rooms on six
pediatric floors, addressing the need for more beds.
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Nurses and doctors don’t have to trundle around
a computer on a cart to record a patient’s progress.
Each room has its own computer, which folds
into the wall like a Murphy bed. This in-room
charting further reduces hallway traffic, keeping
patient areas quieter.

AU TO M AT E D G U I D E D
V E H I C L E  AG V 
Robots called automated guided
vehicles, or AGVs, transport
supplies from the delivery dock
to supply rooms and haul trash
and other waste. AGVs have their
own dedicated corridors and
elevators, so patients will likely
never see them.
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On Match Day, March 16, thousands of physicians-to-be across the U.S. learned
where they will train as medical residents after graduation. Of the 119 graduating
Washington University medical students, 42 will train at Barnes-Jewish Hospital
and four at St. Louis Children’s Hospital. Altogether, this year’s class will be
represented at hospitals in 21 states. The largest group of students — 31 —
will train in internal medicine, followed by 13 in diagnostic radiology.
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Chapel Hill
Nashville

1
Salt Lake
City

Stanford 2

Duarte
1
Los Angeles 7
San Diego 2
Dallas 2

Victoria Wesevich

FLORIDA
Jackson Memorial Hospital
ORTHOPAEDIC SURGERY

Michael Rizzo

GEORGIA
Emory University
School of Medicine
INTERNAL MEDICINE

Sarah Wondmeneh

1
Atlanta

ILLINOIS
Northwestern McGaw/NMH/VA
INTERNAL MEDICINE

Seren Gedallovich

Houston 3

RADIOLOGYDIAGNOSTIC

Nicholas Szrama

1 Miami

UIC/Mount Sinai Hospital
Medical Center
SURGERYGENERAL

Michelle Mendiola-Pla
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INDIANA
Indiana University
School of Medicine
OBSTETRICS AND GYNECOLOGY

Amanda Boozalis
ORTHOPAEDIC SURGERY

Casey Beleckas

MARYLAND
Johns Hopkins Hospital
ANESTHESIOLOGY

Christelle Samen
INTERNAL MEDICINE

Nora Burdis
OTOLARYNGOLOGY

Nicholas Scott-Wittenborn

University of Maryland
Medical Center

OBSTETRICS AND GYNECOLOGY

Mary Dandulakis

MASSACHUSETTS
Beth Israel Deaconess
Medical Center
INTERNAL MEDICINE

Julia Berg
Ryan Kronen

Brigham & Women’s Hospital
INTERNAL MEDICINE

Victor Kovac
Michelle Robinette

Children’s Hospital-Boston
PEDIATRICS/URBAN
HEALTH ADVOCACYBMC

Sagar Mehta

Massachusetts General Hospital
INTERNAL MEDICINE

Monica Kasbekar
INTERNAL MEDICINE
PRIMARY CARE

INTERNAL MEDICINE

Bilal Al-Khalil
Eleanor Christenson
Amarilys Fernandez-Maldonado
Douglas Hall
Sonya Liu
Jeffrey Marinshaw
Patrick Olson
Cliff Pruett
Morgan Schoer
Andrea Soares
Stephanie Teja
Andrew Young
Shiyang Zhang
NEUROLOGICAL SURGERY

Diane Aum
Ridhima Guniganti
Rowland Han
NEUROLOGY

Manouela Valtcheva
OBSTETRICS AND GYNECOLOGY

Manuela Mejia
Lulu Yu
ORTHOPAEDIC SURGERY

Thomas Hong
Andrea Tian
PSYCHIATRY

Angela Lin
Dylan Powell
Joshua Siegel
Emily Slat
Lingjin Zheng
RADIOLOGYDIAGNOSTIC

Katerina Konstantinoff
Christopher Mejias
Adam Naylor
Caroline Robb
Eric Weiner
Alec Wright
SURGERYGENERAL

New York Presbyterian
Hospital-Columbia University
Medical Center
INTERNAL MEDICINE

Laura Lee

New York Presbyterian HospitalWeill Cornell Medical Center
INTERNAL MEDICINE

Xiaodi Wu

New York University
School of Medicine
INTERNAL MEDICINE

Paolo Dib
RADIOLOGYDIAGNOSTIC

Sindhoora Murthy
SURGERYGENERAL

Aaron Zuckerman

University of North Carolina
Hospitals
ORTHOPAEDIC SURGERY/
RESEARCH

Alexander Padovano

Wake Forest Baptist
Medical Center

SURGERYGENERAL

Diana Jiang

OHIO
Case Western/University Hospitals
Cleveland Medical Center
PEDIATRICS

William Cheng

Cleveland Clinic Foundation
INTERNAL MEDICINE

Rubabin Tooba

University of Cincinnati
Medical Center

Radhika Jain
INTERVENTIONAL
RADIOLOGY INTEGRATED

Naveen Pokala

OREGON

SURGERYGENERAL

PEDIATRICS

Avril Coley

Elizabeth Daniels
Julia Kolodziej
Kristen Rosano
Jeannette Wong-Siegel

Oregon Health & Science
University

Avik Som
SURGERYPRELIMINARY

Max Riley

MICHIGAN
University of Michigan
Hospitals-Ann Arbor
ANESTHESIOLOGY

Shagun Mathur
INTERNAL MEDICINE

Kunal Mathur

M I N N E S OTA
University of Minnesota
Medical School
OBSTETRICS AND GYNECOLOGY

Jessica Holttum

MISSOURI
Barnes-Jewish Hospital
CLINICAL PATHOLOGY

Gary Grajales-Reyes
DERMATOLOGY

Cristopher Briscoe
Stephen Erickson
Christine Yokoyama
EMERGENCY MEDICINE

Elizabeth Christiansen
Katherine Stanley

outlook.wustl.edu

St. Louis Children’s Hospital

St. Louis University
School of Medicine
DERMATOLOGY

Gabriela Morris
FAMILY MEDICINE

Mindy Guo

University Hospitals-Columbia
INTERNAL MEDICINE

Alexander Markov

Washington University
OPHTHALMOLOGY

Brent Bruck

NEW YORK
Hospital for Special Surgery
ORTHOPAEDIC SURGERY

Gregory Schimizzi

Montefiore Medical
Center/Einstein

EMERGENCY MEDICINE

Michael Del Valle

OBSTETRICS AND GYNECOLOGY

Gregory Opara

University of Texas
Southwestern Medical School
PEDIATRICS

Benjamin Masserano
RADIOLOGY DIAGNOSTIC/
RESEARCH

Dong Young Lee

U TA H
University of Utah
Affiliated Hospitals
PLASTIC SURGERY
INTEGRATED

Bo Overschmidt

NORTH CAROLINA WASHINGTON

Kenneth Newcomer
Jorge Zarate Rodriguez
SURGERYPRELIMINARY

University of Texas Medical School

Kadlec Regional Medical Center
FAMILY MEDICINE

Jennifer Farley

University of Washington
Affiliated Hospitals
ORTHOPAEDIC SURGERY

Taleef Khan
SURGERYPRELIMINARY

Daniel Kaufman

WISCONSIN
Medical College of Wisconsin
Affiliated Hospitals
PSYCHIATRY

Emily Rion

University of Wisconsin
Hospital and Clinics
RADIATION ONCOLOGY

Emily Merfeld

DERMATOLOGY

Tyler Bauman

EMERGENCY MEDICINE

Galen Pizzorno

P E N N S YLVA N I A
Hospital of the University
of Pennsylvania
FAMILY MEDICINE

Rachel Springer

Wills Eye Residency Program
at Jefferson
OPHTHALMOLOGY

Vikram Shankar

TENNESSEE
Vanderbilt University
Medical Center
INTERNAL MEDICINE

Nowrin Haque
RADIOLOGYDIAGNOSTIC

Jessica Miller

TEXAS
Baylor College of Medicine

Match Day 2018 participants
from former School of
Medicine classes:
Anchal Bansal (2017
graduate), Anesthesiology,
Barnes-Jewish Hospital
Michael Lamb (2001 graduate),
Anesthesiology, University of
Texas Medical Branch, Galveston
Adam Letvin (2017 graduate),
Internal Medicine, University
Hospitals, Columbia, Missouri
Jennifer Jupitz Pitts
(2014 graduate), RadiologyDiagnostic, University of
Wisconsin Hospital and
Clinics, Madison
Tara Rao (2017 graduate),
Internal Medicine-Primary
Care, University of Wisconsin
Hospital and Clinics, Madison
Tammy Ruth (2013 graduate),
Pediatrics, University of
Washington Affiliated
Hospitals, Seattle

INTERNAL MEDICINE
PEDIATRICS

Elizabeth Maidl
PEDIATRICS/MEDICAL
GENETICS

Runjun Kumar

See more photos online:
wumcnews.org/match2018
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Gaining J
mobility

ackie and Randy Baker understand the pain

and loss of mobility associated with arthritis —
and the relief of recovery. To address their

arthritis, doctors at the School of Medicine’s
Department of Orthopaedic Surgery replaced their
hips and guided them through rehabilitation. Now,

New strategies to preserve
hip function, improve outcomes
BY CHANNING SUHL

with their mobility restored, the
Bakers are passionate about bringing
the gift of restoration to others.
Hip surgeon John Clohisy, MD, the
Daniel C. and Betty B. Viehmann
Distinguished Professor and chief of
Adult Reconstructive Surgery,

John Clohisy, MD

performed the Bakers’ surgeries.
Physiatrist Heidi Prather, DO,
professor and chief of physical
medicine and rehabilitation, advised
the Bakers on alternative methods of
relief prior to the surgeries.

Heidi Prather, DO

Through their interactions with Clohisy and
Prather, the Bakers learned about the physicians’
efforts to advance the treatment of musculoskeletal
disorders. As a result, the Bakers decided to make a
series of financial gifts supporting the research.
The Bakers’ gifts will help the physicians find
solutions that range from new surgical alternatives

GETTY IMAGES

to a fundamental shift in the care model.

28 Washington University School of Medicine
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Investigating arthritis

“We have been impressed not
only by her care for us, but
especially by her interest in
Traditional treatment of advanced
hip arthritis has centered on
improving patient outcomes
joint replacement surgery. These
and well-being through
procedures are very effective for
interdisciplinary approaches.”
pain relief but can be associated
In 2017, the couple learned
with limited function and longof Prather’s plan to create the
term implant failure requiring a
Living Well Center at Barnessecond, riskier revision surgery.
Jewish West County Hospital,
For nearly two decades, Clohisy
and eagerly provided funding.
and his collaborators have focused
As the center works toward
on pre-arthritic and early arthritic
becoming a reality in 2019,
hip disorders and hip joint
Prather said, “The support of
replacement. The multidisciplinary St. Louisans Jackie and Randy Baker have made a series of
philanthropists like the Bakers
gifts supporting arthritis research and recovery initiatives.
team has established a worldis crucial.”
renowned clinical practice,
A collaboration between the
research unit and resident/fellow education programs.
hospital and the School of Medicine, the proposed center
Yet, there is still a critical need for additional research to
will provide comprehensive, interdisciplinary medical
improve understanding of hip arthritis causes.
services for patients with musculoskeletal disorders.
“Future strategies to cure arthritis must focus on early
A team of health-care professionals will identify patients
diagnosis and innovative treatments to preserve the natural
at high risk for poor treatment outcomes (based on existing
hip joint and prevent disease progression,” Clohisy said.
medical, physical and behavioral health disorders), develop
These initiatives are aimed at early detection of hip
individualized care plans for these patients and meet
disease; evaluation of newer surgical alternatives that
regularly to discuss their progress and any treatment barriers.
correct abnormal hip anatomy leading to arthritis onset
This wellness center concept is unique because it
and progression; arthritic disease staging; and clinical
provides health-care services, such as smoking cessation,
outcomes of joint preservation procedures.
nutritional counseling and exercise instruction, which
Clohisy’s team is investigating biological factors that
third-party payers often do not cover.
can be used for disease staging and joint prognosis. To
date, circulating biomarkers and joint tissue markers
associated with hip arthritis progression and disease stages
have not been clearly defined.
As federal funds usually are not available during the
early research phase, gifts from private individuals provide
extremely important start-up resources.
“We hope that this research will result in significant
Through this personalized, holistic approach, the
progress toward Dr. Clohisy’s vision to develop and refine
center will give patients self-care tools to positively
innovative treatments to preserve natural hip joint function
impact their well-being. “The end goal is for patients to
and prevent hip arthritis,” Randy Baker said.
self-manage their musculoskeletal disorders and have
improved overall health that is sustainable,” Prather said.
“For surgical patients, the goal is improved pain outcomes
Treating the whole patient
and functionality with reduced risk of complications, in
addition to improved health.”
Prather specializes in the conservative management of
Prather said she has not found another musculoskeletal
musculoskeletal conditions, pre-arthritic hip disorders
care model that incorporates all factors known to affect
and hip and lumbar spine connections. She is past
treatment outcomes.
president of the North American Spine Society — the
Eventually, the pilot center may expand into a regional
first woman elected to the position — and internationally
center that anyone can access.
known in the field.
“By breaking down barriers to coordinated care, we
The Bakers contributed in 2015 toward Prather’s
hope the center will become a model for other healthmusculoskeletal research.
care facilities,” said Jackie Baker, “and ultimately improve
“Over the years, several members of our family
patient outcomes and the cost effectiveness of the
have been treated by Dr. Prather,” Jackie Baker said.
health-care system.”

“The support of philanthropists
like the Bakers is crucial.”
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Before A
it begins

bequest by the late
Daniel J. Brennan, MD,
is supporting significant

advancements in Alzheimer’s disease
research at the School of Medicine. The
disease affects 5.5 million Americans — a number

Family, researchers team up
to cure — or even prevent —
Alzheimer’s disease
BY CHANNING SUHL

expected to climb rapidly as people live longer.
Following Brennan’s death in 2010, the estate gift
created the Daniel J. Brennan, MD, Research Fund
in the Charles F. and Joanne Knight Alzheimer’s
Disease Research Center (Knight ADRC). In 2017, at
the family’s request, a portion of the gift was used to
establish the Daniel J. Brennan, MD, Professorship

Beau Ances, MD, PhD, MSc, second
from left, becomes an endowed
professor. Joining in on the
celebration are (from left): David
H. Perlmutter, MD, executive vice
chancellor for medical affairs and
dean of the School of Medicine;
Chancellor Mark S. Wrighton; and
Daniel J. Brennan II.
30 Washington University School of Medicine

MATT MILLER

in Neurology, further extending its impact.

Spring 2018

HUY MACH

Born in St. Louis, Brennan trained at Saint Louis University
— earning undergraduate and medical degrees and completing
a general surgery internship and residency and a plastic and
reconstructive surgery residency. A gifted plastic surgeon,
Brennan practiced at St. John’s Mercy Medical Center (now
Mercy) until 1997 as a member of Plastic Surgery Affiliates.
As a longtime benefactor of medical education and
research, Brennan chose Washington University School of
Medicine for his estate gift because of its national leadership
in Alzheimer’s disease research.
Brennan’s son, Daniel J. Brennan II, said the gift reflects
the things his father valued in his own career. “My father
dedicated most of his adult life to medicine — and caring
for people,” he said. “It was his passion. To have his name
associated with such a prestigious university, and a leader
of Alzheimer’s research, fits with his desire to leave a mark.
It also fits with his desire for excellence.”

John C. Morris, MD, director of the Charles F. and Joanne Knight
Alzheimer’s Disease Research Center, performs a neurological exam
on a patient. A long-term study of adult children of Alzheimer’s
patients aims to define who is likely to develop the disease.

Uncovering the progression

Fulfilling a legacy

John C. Morris, MD, the Harvey A. and Dorismae Hacker
Friedman Distinguished Professor of Neurology, leads the
Knight ADRC, located in the Department of Neurology. The
center and its clinical research arm — the Memory and Aging
Project (MAP) — are at the forefront of a worldwide effort to
uncover key causal factors in Alzheimer’s disease and improve
early diagnosis, with a goal of finding more effective treatments,
an eventual cure or even preventing the illness entirely. The
researchers believe that beginning preventive treatment before
brain damage occurs is essential to halting disease progression.
Morris leads a team focused on improving early-stage
diagnosis, identifying preclinical stages of Alzheimer’s
disease by biomarker and neuroimaging studies, evaluating
new drugs for the treatment of dementia and establishing
phenotypes for inherited forms of Alzheimer’s disease and
other dementias. Volunteer research participants, including
those who are aging normally and those with dementia, and
family members have been major contributors. They take
part in annual assessments through the MAP and various
other studies, such as clinical drug trials, and provide
biological and imaging specimens.
Morris also is the principal investigator of the Adult
Children Study, a long-term study of adult children of
Alzheimer’s patients — led by the School of Medicine —
that aims to define who is likely to develop the disease and
when, and to establish a timeline for how quickly the disease
will progress. The study, which began in 2005 with funding
from the National Institute on Aging of the National
Institutes of Health (NIH), already has helped identify some
of the molecular and structural changes in the brain that
occur in the decades before a person is diagnosed with the
neurodegenerative disease.

According to Dan Brennan II, establishing a professorship
was an important step in fulfilling his father’s wishes.
“As long as I can remember, he spoke of a desire to have an
endowed professorship in his name as part of his legacy,”
he said. “And I’m proud to have my daughters — Mackenzie,
Livia, Danielle and Sylvia — involved and witness the impact
of the legacy that my father has left behind.”
In February, neuroimaging expert Beau Ances, MD, PhD,
MSc, was installed as the inaugural Daniel J. Brennan, MD,
Professor of Neurology. Ances is a professor of neurology,
neurosciences and molecular microbiology and microbial
pathogenesis at the School of Medicine and of biomedical
engineering at the School of Engineering & Applied Science.
He also is a member of the Knight ADRC and the Hope
Center for Neurological Disorders.
The Ances lab has been at the forefront of developing
novel neuroimaging methods to understand the timeline
of change seen in both sporadic Alzheimer’s disease and
autosomal dominant Alzheimer’s disease. The vision of the
Ances lab is to find neuroimaging biomarkers that will allow
for Alzheimer’s disease diagnosis and evaluate the efficacy of
potential therapies.
While Alzheimer’s research primarily has focused on the
accumulation of the protein amyloid beta, researchers now are
paying closer attention to another protein, tau. Long associated
with the disease, tau is not easy to visualize through imaging
and, as a result, has not been thoroughly studied.
Using a new binding agent that makes tau protein visible
on positron emission tomography (PET) scans, Ances and
his colleagues have shown that measures of tau are better
markers of the cognitive decline characteristic of Alzheimer’s
than measures of amyloid beta protein. This allows for a
better understanding of Alzheimer’s progression.
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CLASSNOTES

Find your friends.
Classnotes are organized first by
year of degree/training completion
and then in alphabetical order.

How about you?
Share your news via the online
form at wumcnews.org/classnotes.
Submissions will be printed in
a subsequent issue of Outlook
magazine as space allows. Photos
are welcome.

1950 S
Max Heeb, MD ’53,
who practiced general
surgery for more than 45
years in rural Missouri,
received a distinguished
service award from the
University of Missouri
School of Medicine on
April 21, 2017. He is author of the book
“Max the Knife: The Life and Times of a
Country Surgeon.”
Roger Meyer, MD ’55, stays active with
volunteering, supporting peace activities
with Rotary International, Peace Action with
the Unitarians and the Physicians for Social
Responsibility, and serves on the Oregon
Health & Science University BRAINet
board as historian. His work with Rotary
International’s Fellowship of Doctors as vice
president is helping promote telemedicine
and end-of-life practices. He also enjoys a
busy family life with four of his six children
in Portland, Ore., and looks forward to
celebrating his 90th birthday in May.

1960 S
Mordecai Blaustein,
MD ’61, recently
published an invited
40-year update on
an article he wrote
when he was on the
Washington University
32 Washington University School of Medicine

faculty in 1977. In this widely cited article, he
postulated that an endogenous digitalis-like
compound plays a role in the pathogenesis
of hypertension. The update is Blaustein’s
personal account of how he and his colleagues purified and identified endogenous
ouabain (EO) in human plasma. The article
reviews the astonishing evidence that ouabain (first identified as a plant steroid that
was used as an arrow poison for centuries)
is an adrenocortical hormone. EO and its
plasma membrane receptor, the sodium
pump, are a novel endocrine system that
influences behavior, cardiovascular function, fetal development and muscle fatigue.
Blaustein chaired the University of Maryland
Department of Physiology from 1979-2003
and is still an active faculty member. His
awards include the Pasarow Foundation
Award for Cardiovascular Research, the
American Heart Association Hypertension
Council Novartis Award for Hypertension
Research and the University of Maryland
Baltimore 2002 Faculty Research Lecturer of
the Year Award.
Kurt Studt, LA ’63, DE ’66, retired from
active dental practice after more than 50
years. During his career, he taught dental
students at Washington University and
at Southern Illinois University School of
Dental Medicine. Studt is currently an
adjunct faculty member in the dental
hygiene program of St. Louis Community
College at Forest Park.
Lynn Taussig, MD ’68, retired in
December from the University of Denver,
where he served as special adviser to the
provost for life sciences for the past 12
years. He previously served as president/
CEO at the National Jewish Medical and
Research Center, now called National
Jewish Health, and was on faculty at the
University of Arizona College of Medicine,
where he served nine years as chair of
the Department of Pediatrics. Taussig
is proud to have initiated the Tucson
Children’s Respiratory Study in 1979, a
major longitudinal study of asthma risk
factors in 1,246 newborns. The study
continues today. One paper emanating
from this study has had nearly 4,000
citations. Taussig is grateful for the many
honors given by his peers and mentors,
including the Alumni Achievement Award

from Washington University School of
Medicine, the Distinguished Achievement
Award from the American Thoracic Society,
the Kendig Award from the Academy of
Pediatrics, The Founders Award from the
Scientific Assembly on Pediatrics of the
American Thoracic Society, and election
into the Colorado Pulmonary Hall of Fame.

1970 S
Richard Wahl, MD ’78, HS ’83, the
Elizabeth E. Mallinckrodt Professor of
Radiology and director of the Mallinckrodt
Institute of Radiology, Samuel I. Achilefu,
PhD, the Michel M. Ter-Pogossian Professor
of Radiology, and Pamela K. Woodward,
MD, professor of radiology, recently
received a five-year, $933,700 grant from
the National Institutes of Health (NIH) for
Training Opportunities in Translational
Imaging Education and Research (TOPTIER). This new interdisciplinary clinicianscientist postdoctoral program will prepare
residents and fellow trainees on how to
bring preclinical imaging innovations to
patients and the practice of medicine.

1980 S
Joseph Moskal, MD ’81,
chair of the Department
of Orthopaedic Surgery
for Carilion Clinic and
the Virginia Tech Carilion
School of Medicine,
has been appointed
to the Dean’s Council
on Advancement for the Virginia Tech
Carilion School of Medicine. The council
is a committee of volunteers created
to advance the stature of the medical
school by providing guidance, assistance,
advocacy and philanthropic investment in
support of the school’s strategic objectives.
Raymond Curry, MD ’82,
was recognized by the
Northwestern University
Feinberg School of
Medicine with the
creation of a named
professorship in medical
education, endowed by
an anonymous donor in honor of his 16 years
Summer 2018

of service to the institution as vice dean for
education. Curry is now the senior associate
dean for educational affairs at the University
of Illinois College of Medicine and clinical
professor of medicine and medical education
at the University of Illinois at Chicago.
Sándor J. Kovács, PhD, MD, HS ’85,
professor of medicine and of cell biology
and physiology, was honored with a Lifetime
Achievement Award from the Barnes-Jewish
Hospital Medical Staff Association. The award
was presented at the association’s semiannual general staff meeting, April 13, 2017.

1990 S
Audrey Shillington, SW
’87, SW ’91, GM ’93,
director of the Colorado
State University School
of Social Work, assumed
responsibilities as
associate dean for
academic affairs in the
College of Health and Human Sciences in
June 2017. Shillington remains director of
the social work school and is professor of
epidemiology at the University of Colorado
School of Public Health. She was a National
Institute of Mental Health postdoctoral fellow
and earned a master’s degree in psychiatric
epidemiology from Washington University
School of Medicine. She has published in
the areas of psychometrics, epidemiology,
prevention and intervention work aimed at
adolescent and young adult risk behaviors.
She has been principal investigator and
co-investigator on grants totaling more than
$14 million, including those from the National
Institutes of Health (NIH), the National
Institute on Drug Abuse and the National
Institute on Alcohol Abuse and Alcoholism.
Her current work focuses on intervention and
prevention related to the changing landscape
in legalization of recreational marijuana use.

Deborah Veis Novack, MD ’95, PhD ’95,
participated in the Rally for Medical
Research in Washington, D.C., in September
2017. This annual event brings together
300-plus researchers, clinicians and patient
advocates from hundreds of organizations
to meet in the offices of senators and
representatives to demonstrate the value
of medical research to all citizens. Through
this type of advocacy, Congress has
provided $2 billion increases in National
Institutes of Health (NIH) funding each of
the last two years, and a similar increase is
proposed for the FY2018 budget.
Bryan Meyers, HS ’98,
chief of the general
thoracic surgery
section at Washington
University School of
Medicine, has been
named chair of the
American Board of
Thoracic Surgery. He will serve as chair for
two years.
Edward Garon, MD ’99,
director of the Thoracic
Oncology Program at the
Jonsson Comprehensive
Cancer Center at the
University of California,
Los Angeles, and associate
professor of medicine
in the Division of Hematology-Oncology
at David Geffen School of Medicine, joined
LUNGevity’s scientific advisory board, a
group of 19 world-renowned scientists and
researchers who guide LUNGevity’s scientific
strategy and research program. LUNGevity
focuses on early detection of lung cancer.

2000 S
Jimmy Kerrigan, MD ’10, is an interventional cardiology fellow at Cleveland
Clinic and is married with children.

Michael Raney, MD ’94, a radiologist
with West County Radiological Group in
St. Louis, was elected secretary-treasurer
of the Missouri Radiological Society.

Vanessa Williams, LA ’06, MD ’10, is
an assistant professor of radiology at
the University of Kansas. She is married
with children.

Bryan Gibby, PT ’95, is a certified wound
specialist at St. Luke’s Elks Wound Center in
Boise, Idaho.

Tassy Hayden, LA ’07, MD ’11, practices at
Southampton Healthcare in St. Louis, a large
primary medicine group with an emphasis
on caring for the LGBT community.
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David Jin, EN ’06, MD ’11, is a clinical
research fellow in gastroenterology,
hepatology and endoscopy at Brigham and
Women’s Hospital at Harvard Medical School.
Jesse Otero, MD ’11, PhD ’11, is an
orthopaedic surgeon at the University of
Iowa Hospitals and Clinics. He is married
with children.
Catherine Butler, MD ’12, is a research
nephrology fellow at the University of
Washington.
Adam Rouse, EN ’04, SI ’12, MD ’12, is a
research assistant professor in neuroscience
at the University of Rochester and received
a National Institutes of Health (NIH)/
National Institute of Neurological Disorders
and Stroke K99/00 grant in April 2017.
Lucy Zhang, MD ’12,
of San Francisco, is
an ophthalmologist
with Peninsula
Ophthalmology
Group at its Daly
City and Burlington,
Calif., offices.
Yi Wang, MD ’13, of Houston, recently
was married and traveled to Italy on her
honeymoon and describes it as a beautiful
and poignant experience. She is happy to
report having survived Hurricane Harvey
without much damage. Wang works as a
pediatrician at Legacy Community Health.
Megan Cook, PT ’14, was married to
Aaron Shoppa in September 2017. She is
a physical therapist at Advocate Children’s
Hospital in Oak Lawn, Ill.
Jennifer Jupitz, MD
’14, is stationed at Camp
Lejeune in North Carolina
serving as the physician
to a squadron in the U.S.
Marine Corps. She was
married in 2016, and
she and her husband
welcomed a baby boy in fall of 2017.
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OBITUARIES

David A. Bensinger, LA
43, DDS, former dean of
Washington University’s
School of Dental
Medicine, died Saturday,
July 22, 2017, in San
Francisco. He was 91.
Bensinger joined
the faculty in 1948 as an instructor of
dental medicine. He became an associate
professor in 1956, was named assistant
dean in 1967, associate dean in 1973 and
full professor in 1976. A major renovation
of the School of Dental Medicine building
was completed under his supervision in
1972. In 1987, Bensinger was appointed
dean, serving until his retirement in 1989.
The Washington University Alumni
Association named him Alumnus of the
Year in 1968, honoring his work to prevent
closure of the school the previous year.
A specialist in periodontics, Bensinger
served as president of the Midwestern
Society of Periodontists; he also served as
president of the Missouri Dental Association
and was also a fellow of both the American
College of Dentists and the International
College of Dentists.
He is survived by his wife of 42 years,
Susanna; children and step-children Judith
(William) Haynes, Scott (Vicki) Bensinger,
Ruth Hartman (Gary Wolff), Emily (Avraham)
Eisbruch and Sara Yashar (Mayer z”l); 11
grandchildren and three great-grandchildren.
Ari Nachum Berlin, MD,
a pediatric intern at
St. Louis Children’s
Hospital and a 2017
graduate of the School
of Medicine, died Feb.
23, 2018, in St. Louis,
after a 2 ½-year battle
with pancreatic neuroendocrine cancer.
He was 27.
Berlin grew up near Boston. He earned
a bachelor’s degree in chemistry in 2012
at Rice University.
He met his future wife, Hallie Morris,
while both were students at the School of
Medicine. The couple married Jan. 7, 2017,
and worked together for a brief time at
St. Louis Children’s Hospital. Morris, MD,
is a fellow in newborn medicine.
34 Washington University School of Medicine

Berlin was diagnosed with cancer while
in medical school. Following his diagnosis,
his parents moved to St. Louis from
Massachusetts to offer additional support.
Berlin is survived by his wife; his parents,
Kenny Berlin, MD, and Marsha Ross-Berlin,
DMD; a brother, Josh Berlin; a sister, Jessie
Berlin; and his grandmother, Maxine Berlin.
Arthur Z. Eisen, MD, a
physician-scientist who
founded and led the
Division of Dermatology,
died Sunday, Nov. 12,
2017, in St. Louis after a
short illness. He was 88.
Eisen founded the
division in 1967 and remained its director for
more than 30 years. During that tenure, he
was the Winfred A. and Emma R. Showman
Professor of Dermatology. Until his retirement
last year, he remained active in clinical
medicine and resident education.
“Dr. Eisen was one of the true giants in
the field of dermatology,” said Lynn Cornelius,
MD, director of the Division of Dermatology.
“He embodied the quintessential ‘triple
threat’ throughout his illustrious career —
outstanding in research, clinical medicine
and education.”
Eisen was considered a longtime leader
in connective tissue research. He focused
on the genetic underpinnings of skin
diseases and the role enzymes play in
remodeling tissue, and was particularly
interested in the cells that synthesize
collagenase-1 in the dermal layer of skin.
He earned a bachelor’s degree from the
University of Buffalo in 1951, a master’s
degree from Brown University in 1953, and
a medical degree from the University of
Pennsylvania in 1957. He completed an
internship, residency and fellowship at the
University of Rochester School of Medicine
and Dentistry.
Eisen is survived by his wife of 59 years,
Mimsie Eisen; their son, Marshall (Gail) Eisen;
daughters Phyllis (Alex) Kane, and Leah
(Steve) Pazol; and several grandchildren.

Stephen L. Johnson,
PhD, a national leader
in the field of zebrafish
genomics and a
professor of genetics,
died at his home Friday,
Dec. 15, 2017, after a
long struggle with
rheumatoid arthritis. He was 56.
Johnson guided the development of
zebrafish as an important research model,
similar to fruit flies and mice. With transparent
embryos, zebrafish are ideal for studying
growth and development.
Johnson’s zebrafish studies have shed
light on how tissues regenerate and how
organisms control the size of their organs.
He was particularly interested in
understanding cells called melanocytes,
which are best known for governing skin
pigmentation and are the cell type affected
in the deadliest form of skin cancer,
melanoma. Johnson developed methods to
track the fate of these cells as they develop
from the early embryo to the adult zebrafish.
Johnson earned a bachelor’s degree in
chemistry and molecular biology at Vanderbilt
University, followed by a doctoral degree in
genetics from the University of Washington,
Seattle. He continued postdoctoral training at
the University of Oregon before joining the
Washington University faculty in 1996.
Johnson is survived by his sister,
Susan C. Johnson; his brother, Lee
Johnson; and several nieces.
William M. Landau, MD,
a professor emeritus of
neurology, died in his
sleep Thursday, Nov. 2,
2017, at his home in
University City. He was 93.
Landau was a
professor of neurology
from 1954 to 2012 and served as head of
the Department of Neurology from 1970 to
1991. He was the longest-serving faculty
member at the School of Medicine.
Landau specialized in movement
disorders such as Parkinson’s disease, but
his interests ranged widely. With Frank
Kleffner, of the Central Institute for the
Deaf, he identified and described LandauKleffner syndrome, a rare disorder in which
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children lose the ability to speak and
respond to language. He also studied
how patients fared who were revived with
CPR after their hearts had stopped beating,
and concluded that the risk of severe,
debilitating brain damage was underappreciated. He advocated for more limited
use of the procedure.
The Department of Neurology established
the William & Pudge Landau Lectureship in
Neuroscience and Society in honor of Landau
and his wife, known as Pudge, whom he
married in 1947. Along with his scientific
accomplishments, Landau was known for his
commitment to social justice.
Landau was born just a few blocks from
Washington University in 1924. He started
college at the University of Chicago in 1941,
but the United States’ entry into World War
II accelerated his college career, and after
just two years, he returned to St. Louis to
begin medical studies at Washington
University School of Medicine. He was 18.
In addition to his daughter, Julie LandauTaylor, he is survived by three sons, David
Landau of St. Louis, John Landau of New
Jersey and George Landau of Philadelphia;
11 grandchildren; and four greatgrandchildren.
Arthur DeCosta Loewy,
PhD, professor of
anatomy and of
neuroscience, died
Saturday, Dec. 2, 2017,
of complications related
to inflammatory bowel
disease and other health
issues. He was 74.
Upon joining the School of Medicine
faculty in 1975, Loewy focused his research
on the ways the brain regulates bodily
functions such as blood pressure. He is best
known for discovering the anatomical basis
of the fight-or-flight response. Early in his
career, he used radioactively tagged
molecules to trace the pathway that
connects the brain to the pacemaking
neurons in the heart.
Loewy earned a bachelor’s degree in
mathematics from Lawrence University in
Appleton, Wis., followed by a doctoral
degree in anatomy from the University of
Wisconsin, Madison.
outlook.wustl.edu

Loewy was preceded in death by his
wife, Arleen Loewy, who also had worked at
Washington University. In addition to his
son, Adam Loewy, he is survived by his
daughter-in-law, Philippa (Rudolph) Loewy;
his long-term girlfriend, Karen Frahm; a
grandson; and his daughter-in-law’s
parents, Christy Twin and Larry Rudolph.
John E. Majors, PhD,
professor emeritus of
biochemistry and
molecular biophysics,
died Wednesday, Jan.
10, 2018, of a heart
attack. He was 69.
Majors was known
for key contributions to the field of
molecular biology, particularly involving the
expression of genes in yeast and viruses. He
worked with a team led by Harold E. Varmus,
MD, and J. Michael Bishop, MD, whose
research revealing how viruses can cause
cancer was honored with the Nobel Prize in
Physiology or Medicine in 1989.
According to colleagues, Majors was
deeply committed to mentorship and
training, putting students at the center of
his work. He served on the doctoral thesis
committees of more than 100 graduate
students in the Division of Biology &
Biomedical Sciences (DBBS). In 2013, he was
one of 10 DBBS faculty named to “The One
Hundred Club,” honoring this achievement.
Many of his former trainees have gone on
to become leaders in their fields.
Majors earned a bachelor’s degree in
physics from the University of Washington
in 1970 and a doctoral degree in biophysics
from Harvard University in 1977. He trained
as a postdoctoral fellow in Varmus’ lab, then
at the University of California, San Francisco
— contributing to the discoveries that
would later earn Varmus and Bishop the
Nobel Prize.
He joined the Washington University
faculty in 1983. After his retirement in 2011,
he continued teaching regularly for the
university’s Department of Biology.
Majors is survived by his sisters, Anne
Chick and Jane Sutherland, and their families.

Eric P. Newman, JD,
St. Louis businessman,
scholar and philanthropist
— an alumnus and major
benefactor to Washington
University — died
Wednesday, Nov. 15,
2017, at his home in
Clayton. He was 106 years old.
Born in St. Louis, Newman graduated
from John Burroughs School in 1928 and
Massachusetts Institute of Technology in
1932. He graduated from Washington
University’s School of Law in 1935.
Following World War II, Newman began
his career at Edison Brothers Stores Inc.,
where he was an officer and served on the
board until his retirement. From 1988-2005,
he served as president of the Harry Edison
Foundation.
One of the foremost American
numismatists, Newman wrote more than
100 books and articles, including the
pioneering study “The Early Paper Money of
America” (1967), which remains a standard
in the field. His private collection of U.S. and
Colonial American coins and paper money
is considered one of the nation’s finest.
Newman and his family extended
extraordinary generosity to a wide range of
Washington University schools and
programs. At the School of Medicine, the
family helped underwrite the Eric P.
Newman Education Center and endow two
professorships, in addition to supporting
many other programs.
Newman was preceded in death by his
wife of 75 years, Evelyn. He is survived by
his son, Washington University trustee
Andrew E. Newman of St. Louis; daughter,
Linda Newman Schapiro of New York; five
grandchildren; and 10 great-grandchildren.
John A. “Jack” Pierce,
MD, former director of
pulmonary and critical
care and emeritus
professor of medicine,
died Friday, Nov. 24,
2017, in St. Louis
following a long battle
with cancer. He was 92.
Pierce came to the university in 1967 as
the first director of the Division of Pulmonary
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and Critical Care Medicine. He also served as
chief of pulmonary and critical care medicine
at the St. Louis Veterans Affairs Medical Center.
In 1984, Pierce was named the inaugural
Selma and Herman Seldin Professor of
Medicine. He became an emeritus professor
in 1993, but continued to work with medical
students and trainees until recently.
Pierce created the first respiratory intensive
care unit (ICU) at what was then Barnes
Hospital, which was one of the first such ICUs
in the country. He also launched and directed
one of the first National Institutes of Health
(NIH)-sponsored pulmonary research training
programs in the country.
Pierce’s research helped clarify the roles
of specific enzymes in the development
of emphysema.
Pierce is survived by his wife of 33 years,
Susan (Ellis) Pierce; his children, Sheryl, John
Jr. (Margarita) and Robert (Dawn) Pierce; his
wife Susan’s children, Kerstin Starzer (Daryl)
and Nissa Fendler (Mark); 12 grandchildren;
and four great-grandchildren.
Milton J. Schlesinger,
PhD, professor
emeritus of molecular
microbiology, died of
heart failure Friday,
Oct. 27, 2017, at his
home in Berkeley, Calif.,
after a long period of
illness. He was 89.
Schlesinger was a professor of microbiology (later, molecular microbiology) from
1964 until 1999. During his tenure, he twice
served as acting head of his department.
Schlesinger wrote a definitive history of
the microbiology department, starting from
its inception to the present day. He was
named an emeritus professor in 1999.
His work focused on diverse aspects of
viral assembly and replication. “Milton was
one of the first to use the power of defined
viral systems to probe fundamental processes
of protein folding and modification, in
advance of the recombinant DNA revolution,”
said Stephen M. Beverley, PhD, the Marvin A.
Brennecke Professor and head of the
Department of Molecular Microbiology.
Schlesinger and his wife of 62 years,
Sondra Schlesinger, PhD — a Washington
University professor emerita and an
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occasional scientific collaborator with her
husband — moved to Berkeley in 2003,
but were frequent visitors to St. Louis
and maintained a strong interest in
the department.
He is survived by his wife.
Raymond H. “Ray”
Wittcoff, an emeritus
Washington University
trustee and a member
of the School of
Medicine’s National
Council since 2005,
died Tuesday, Jan. 2,
2018, at his home in Phoenix. He was 96.
Wittcoff was elected to the Board of
Trustees in 1974. He and his wife, Roma, also
an emeritus trustee and School of Medicine
National Council member, have been longtime supporters of Washington University.
The Wittcoffs helped fund university
building projects, program initiatives,
scholarships and professorships.
A real estate developer, philanthropist,
civic leader and visionary, Wittcoff helped
bring public television to St. Louis as a
co-founder of KETC/Channel 9.
Wittcoff also was chair of the board
of directors of Washington University
Medical Center and of Jewish Hospital
(now Barnes-Jewish Hospital). He was
instrumental in inaugurating the
Washington University Medical Center
Redevelopment Corp. In 1986, he
established the Raymond H. Wittcoff
Professorship in Biological Chemistry at
the School of Medicine.
A St. Louis native, Wittcoff earned a
bachelor’s degree from the University of
Chicago in 1942, then served as a Navy
lieutenant in World War II.
In addition to his wife, Wittcoff is
survived by his son, Mark; daughter,
Caroline; five stepchildren, Joel, Richard,
Melanie, Marna and Debbie Broida; four
grandchildren; seven stepgrandchildren;
and one stepgreat-grandson.

For full obituaries, visit:
wumcnews.org/obits

1940 S
Elbert H. Cason, MD ’42; Oct. ’17
Roger E. Fox, MD ’49; Jan. ’18
Louis O. Lambiotte, MD ’45; Nov. ’17
Rudolph J. Maffei, MD ’48; Oct. ’17
Annetta McMahon, NU ’42; Nov. ’17
Roberta G. Middelkamp, NU ’49; Feb. ’18
William W. Regan, MD ’47; Oct. ’17
David E. Smith Jr., MD ’44; Nov. ’17

1950 S
Allie Dunlevy, NU ’50; Aug. ’17
Joan Edwards, NU ’51; Sept. ’17
Gerald E. Hanks, MD ’59; Dec. ’17
Robert J. Hickok, PT ’53, HA ’71; Jan. ’18
Carl A. Hirsch, MD ’59; Dec. ’17
Everett L. Jung, LA ’49, MD ’55; Nov. ’17
Jo Ann Koehler, NU ’53; Jan. ’18
Patricia Kolditz, NU ’51; Dec. ’17
Percy E. Luecke Jr., MD ’52; Oct. ’17
Jean Matthews, PT ’55; Oct. ’17
Larry L. McCune, DE ’55; Jan. ’18
Paul S. Meyer, DE ’55, GD ’58; Dec. ’17
Enoch E. Morrow, DE ’53; July ’17
May Yamamoto Omura, NU ’51; Aug. ’17
Lothar H. Pinkers, MD ’55; July ’17
Robert M. Roy, HS; Oct. ’17
Mary Lynne Ruddon, PT ’58; Nov. ’17
Olga S. Smith, OT ’55; Jan. ’18

1960 S
Duane E. Christian, DE ’60; Oct. ’17
Richard P. Jacobs, MD ’69; Jan. ’18
Leonard Jarett, MD ’62; Jan. ’18
William G. Juergens Jr., MD ’61; Jan. ’18
Azmi H. Khazin, LA ’57, MD ’61; Dec. ’17
Elizabeth C. Sowa, MD ’63; Oct. ’17
H. Goff Thompson Jr., LA ’57, MD ’61;
Dec. ’17
Carol F. Williams, HS ’60; Jan. ’18

1970 S
Sharon S. Crandell, MD ’74; Oct. ’17
Michael Bruce Deldin, MD ’75; Dec. ’17

1980 S
Craig W. S. Howe, HS ’81; Jan. ’18
Kevin T. McDonagh, HS ’87; Dec. ’17

1990 S
Richard Ceenan Tam, MD ’99; Jan. ’18

Summer 2018

Medical student Iris Kuo visits
with patient Jerry McCaleb.

MATT MILLER PHOTOS

‘ When you make a lei,
you’re putting a piece
of yourself or your spirit
into it for the recipient.’

F

Top: Kuo presents patients with floral crowns. Bottom: Maria Baggstrom, MD, left,
helps others make haku lei at a workshop.
outlook.wustl.edu

irst-year medical student Iris Kuo’s classmates
were intrigued by the lovely haku lei — a
floral crown — Kuo wore at White Coat
ceremony in the fall. Eager to share her Hawaiian
culture with classmates, the Honolulu native
arranged a workshop to teach them how to make
the colorful crowns. But before long, the idea
blossomed into something even more meaningful:
an opportunity to show kindness to patients coping
with cancer. Some 50 medical students, faculty,
members of the Hawaii Club on the Danforth
Campus, and St. Louis community members with
ties to Hawaii, made the floral crowns. The crowns
were delivered May 1 — Lei Day in Hawaii —to
patients at Siteman Cancer Center. “It was my hope
that, through the haku lei, the patients would feel
our hope, support and aloha for a moment in their
healing process,” Kuo said.
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Changing the skyline Two 12-story inpatient towers built by BJC HealthCare on the

KENT RANEY, CARDINAL AVIATION

Washington University Medical Campus are enhancing patient care. One of the buildings is the Barnes-Jewish
Parkview Tower, which offers roomy, modernized facilities for patients of Siteman Cancer Center and of the Women
& Infants Center. The other is a St. Louis Children’s Hospital tower featuring an expanded newborn intensive care unit
(NICU) and more pediatric beds. A skywalk now connects labor and delivery areas in the Parkview Tower with the
Children’s Hospital NICU. Almost 800 health-care workers, patients and families contributed to the design process.
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